Riskpilot← Back to searchSign inGet full accessSandra Jonasson Hälsa och Naprapati AB
ABActiveOrg 5567888176Norra Agnegatan 34Physiotherapy activities · NACE 8695Est. 20091 employees
Revenue 2025
SEK 890K
+5% vs 2024
EBITDA margin
-3.3%
-156% vs 2024
Equity ratio
15.3%
Financial strength
Net profit 2025
SEK -30K
-163% vs 2024
| Revenue | SEK 890K | +5% |
| EBITDA | SEK -29K | -156% |
| Net profit | SEK -30K | -163% |
| Total assets | SEK 64K | -37% |
| Equity | SEK 10K | -75% |
| Employees | 1 | — |
Legal name
Sandra Jonasson Hälsa och Naprapati AB
Org number
5567888176
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
10 september 2009
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolagets skall bedriva verksamhet inom naprapati, utföra häslokontroller, vaccination, rådgivning inom hälsa, kost, träning, massage, försäljning av hälsorelaterade varor och produkter, sjukskötersketjänster, föreläsningsverksamhet inom relaterade områden och därmed förenlig verksamhet.
Address
Norra Agnegatan 34
Phone
+46703261422
Email
sandra.jonasson73@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 751 | 798 | 859 | 849 | 890 |
| Staff expenses | — | — | −470 | −409 | −404 |
| EBITDA | −145 | −3 | 2 | −12 | −29 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −145 | −3 | 2 | −12 | −29 |
| Net financials | −1 | — | −0 | 0 | −0 |
| Profit before tax | −145 | −3 | 2 | −11 | −30 |
| Tax | 6 | −0 | — | — | — |
| Net profit | −139 | −3 | 2 | −11 | −30 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 94 | 92 | 88 | 102 | 64 |
| Equity | 52 | 49 | 51 | 39 | 10 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 42 | 43 | 37 | 62 | 54 |
| Total debt | 42 | 43 | 37 | 62 | 54 |
EBITDA margin
-3.3%
This company
15.8%
Market median
-121% vs market
20212025
Equity ratio
15.3%
This company
38.2%
Market median
-60% vs market
20212025
Return on equity
-305.1%
This company
18.4%
Market median
-1758% vs market
20212025
Net profit margin
-3.3%
This company
8.1%
Market median
-141% vs market
20212025
Asset turnover
14.01×
This company
1.12×
Market median
+1151% vs market
20212025
Debt / equity
5.55×
This company
0.62×
Market median
-795% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sandra Jonasson Hälsa och Naprapati AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Katharina Jonasson | Deputy Board Member | 0 companies |
| Östen Jonas Jonasson | Deputy Board Member | 0 companies |
| Sandra Cecilia Jonasson Helms | Board of Directors | 0 companies |